Evidence map›Paper›PMID 41258029›Full record

ArticleTranslational psychiatry2025

Behavioral and molecular insights into anxiety in ube3a and fmr1 zebrafish models of autism spectrum disorders.

Godfried Dougnon, Hideaki Matsui

Abstract read
In one paragraph

Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Godfried DougnonDepartment of Neuroscience of Disease, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.ORCID http://orcid.org/0000-0003-1383-5691
Hideaki MatsuiDepartment of Neuroscience of Disease, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan. hide0729@bri.niigata-u.ac.jp.ORCID http://orcid.org/0000-0003-4908-1035

Funding

Japan Agency for Medical Research and Development (AMED) JP23gm1710010MEXT | Japan Society for the Promotion of Science (JSPS) 22K20681, 23K14672MEXT | Japan Society for the Promotion of Science (JSPS) JP 22484842Takeda Science Foundation NA
6 · The paper itself

Abstract

Angelman syndrome and Fragile X syndrome are neurodevelopmental disorders (NDDs) caused by mutations in the UBE3A and FMR1 genes, respectively. However, they share common features such as cognitive and motor deficits, anxiety, and impaired social behavior. In this study, we utilized zebrafish as an animal model to investigate the anxiety-like effects of mutations in these genes across larval and adult stages, employing two widely used behavioral assays: the light-dark test (LDT) and the novel tank diving test (NTT). We conducted detailed analyses of anxiety-like behaviors and exploration patterns in ube3a and fmr1 mutant fish, comparing both genotypes to their respective wild-type (WT) counterparts. Importantly, we analyzed RNA sequencing data from both larvae and adults to better understand the molecular pathways associated with the anxiety profiles of these genotypes. Our results show that larval ube3a mutants did not exhibit significant difference in the LDT compared to the WT; however, they showed significant reductions in distance travelled, velocity, and light-zone exploration during adult stages. In contrast, fmr1 mutants exhibited reduced locomotor activity in the LDT at larval age and hyperactivity and lower anxiety-like behaviors in adulthood. We identify key genes implicated in these behaviors and shared pathways that warrant further investigation for the development of therapies addressing ASD. Ultimately, our results highlight the importance of using different behavioral assays, such as the LDT and NTT, combined with omics approaches like RNA sequencing, to discern the distinct behavioral phenotypes caused by genetic mutations and to create opportunities for better understanding NDDs.

Indexed as

AnxietyAutism Spectrum DisorderBehavior, AnimalFragile X Messenger Ribonucleoprotein 1Ubiquitin-Protein LigasesZebrafish ProteinsAnimalsDisease Models, AnimalFragile X SyndromeMutationZebrafishFragile X Messenger Ribonucleoprotein 1Ubiquitin-Protein LigasesZebrafish Proteins

Identifiers

PMID41258029
PMCPMC12660731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.